Indole derivatives and their use as medicament

Details Indole derivatives and their use as medicament Indole derivatives and their use as medicament

2011-08-30

2011-08-30

O'Sullivan, Peter G (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S313000, C514S331000, C546S162000, C546S171000, C546S277100

Reexamination Certificate

active

08008324

ABSTRACT:
The invention relates to novel indole derivatives of the general formula 1, to their preparation and to their use as medicaments, in particular for treating tumors.

REFERENCES:
patent: 3573294 (1971-03-01), Lang et al.
patent: 5965582 (1999-10-01), Lebaut et al.
patent: 6008231 (1999-12-01), Lebaut et al.
patent: 6232327 (2001-05-01), Nickel et al.
patent: 6344467 (2002-02-01), Lebaut et al.
patent: 6432987 (2002-08-01), Gunther et al.
patent: 6693119 (2004-02-01), Nickel et al.
patent: 6706722 (2004-03-01), Emig et al.
patent: 6987122 (2006-01-01), Menta et al.
patent: 7365081 (2008-04-01), Emig et al.
patent: 2326833 (1999-10-01), None
patent: 19814838 (1999-10-01), None
patent: 490 263 (1992-06-01), None
patent: 3 632 (1965-10-01), None
patent: P0101530 (2001-11-01), None
patent: WO 97/22619 (1997-06-01), None
patent: WO 98/00946 (1998-01-01), None
patent: WO 98/09946 (1998-03-01), None
patent: WO 98/09946 (1998-03-01), None
patent: WO 99/43654 (1999-09-01), None
patent: WO 99/46267 (1999-09-01), None
patent: WO 99/51224 (1999-10-01), None
patent: WO 99/51224 (1999-10-01), None
patent: WO 99/51224 (1999-10-01), None
patent: WO 99/55696 (1999-11-01), None
patent: WO 99/55896 (1999-11-01), None
patent: WO 99/64044 (1999-12-01), None
patent: WO 99/64044 (1999-12-01), None
patent: WO 99/65894 (1999-12-01), None
patent: WO 00/26202 (2000-05-01), None
patent: WO 00/31063 (2000-06-01), None
patent: WO 00/26202 (2000-11-01), None
patent: WO 00/67802 (2000-11-01), None
patent: WO 00/71535 (2000-11-01), None
patent: WO 01/12189 (2001-02-01), None
patent: WO 01/17516 (2001-03-01), None
patent: WO 01/19830 (2001-03-01), None
patent: WO 01/22954 (2001-04-01), None
patent: WO 01/47913 (2001-07-01), None
patent: WO 01/47916 (2001-07-01), None
patent: WO 01/94310 (2001-12-01), None
patent: WO 02/08225 (2002-01-01), None
Chinese Search Rpt, Jun. 16, 2004.
Russion search rpt w/ translation, Apr. 2003.
Norwegian search rpt w/ translation, Mar. 2006.
Bacher Gerald et al, D-24851, A Novel Synthetic Microtubule Inhibitor, Exerts Curative Antitumoral Activity in Vivo, Shows efficacy toward multidrug-resistant tumor cells, and Lacks Nerotoxicity,; Cancer Research, American Associaton for Cancer Research. Baltimore, MD, US, Bd. 61, Nr. 1, 2001, Seiten 392-399, XP-002173885.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Fresneda, Pilar M. et al: Microwave-assisted regioselective synthesis of 2,4-disubstituted imidazoles: imidazoles: nortopsentin D synthesized by minimal effort; retrieved from STN, Database accession No. 134;281011, XP-002193292, 2001.
Bianucci, Anna Maria et al: “Benzodiazepine Receptor Affinity and Interaction of Some n-(indol-3-ylglyoxylyl) amine Derivatives”; J, Med. Chem. (1992), 35(12), 2214-20, XP-001056519.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Polymeropoulos, E. E. et al: “a Peptiedic Binding Site Model for PDE 4 Inhibitors”; retrieved from STN, Database accession No. 134:360953; XP-002193285, 2000.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Podwinski, Bohdan: “Synthesis of Some 5-benzyloxyindole-3-glyoxylic acid amides”; retrieved from STN, Database accession No. 70:37598; XP-002193286, 1966.
Polymeropoulos E. E. et al: “A Peptidic Binding Site Model for PDE 4 Inhitibors”; Quantitative Structure-Activity Relationships, VCH Publishers, Deerfield Beach, FL, US, Bd. 18, Nr. 6, 1999, Seitern 543-547, XP-001022210.
Battaglia, Sandra et al: “Indole Amide Derivatives: Synthesis, Structure-activity Relationships and Molecular Modeling Studies of A New Seires of Histamine H1-receptor Atagonists”; Eur. J. Med, Chem. (1999), 34(2), 93-105, XP-002193281.
Jiang, B. et al: “Synthesis and Cytotoxicity Evaluation of Bis(indlyl) thiazole, Bls(indolyl) pyrazinone and Bis(indolyl)pyrazine: analogues of Cytotoxic Marine Bis(indole) alkaloid”; Bioorg. Med, Chem. (2000), 8(2), 363-371, XP-002193282.
Faul, Margaret M. et al: “A New, Efficient Method for the Synthesis of Bisindolylmaleimides”; J. Org. Chem. (1998), 63(17), 6053-6058, XP-002193283.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Sarstedt, Burkhard et al: “Reactions with Indole Derivatives. XLVIII. A Simple Synthesis of the Staurosporine Aglycon” retrieved from STN, Database accession No. 98;215863; XP-002193287, 1983.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Povalyaeva, O.S. et al: “Synthesis and Properties of N-substituted 4-amino-1, 2-dithiolanes and Related Compounds”; retrieved from STN, Database accession No. 101-72646; XP-002193268, 1984.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Afsah, El Sayed M. et al: “Synthesis and Reactions of N-indol-3-ylmethylakylamines and Related Compounds”; retrieved form STN, Database accession No. 102:6101; XP-002193289, 1989.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Jiang, Biao et al: “Total Synthesis of (.+-.)-Dragmacidin; A Cytotoxic Bis(indole)alkaloid of Marine Origin”; retrieved from STN, Database accesssion No. 11:280941; XP-002193290, 1994.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Martini, Claudia et al; “Specific Inhibition of Benzodiazepine Receptor Binding by Some N-(Indol-3-ylglyoxylyl)amino acid Derivatives”; retrieved from STN, Database accession No. 102:125088, XP-002193291, 1985.
Evans S.M. et al: “Probing the 5-TH3 Receptor Site Using Novel Indole-3-Glyoxylic Acid Derivatives” Medicinal Chemistry Research, Birkhaeuser, Boston, US, Bd. 3, Nr. 5/6, 1993, Seiten 386-406, XP-000956190.
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US; Da Settimo, A. et al: “Synthesis and anti-inflammatory Activity of Some N-(5-substituted indol-3-ylglyoxyl)amine Derivatives”; retrieved from STN, Database accession No. 107:32773. XP-002193264, 1987.
Organic Chemistry Journal, vol. 20, No. 4, 1984, pp. 849-860, compounds XVIb and XIIb, p. 859.
Heterocycles, (1983), 20(3), pp. 469-476, compounds 8 and 10, pp. 471 and 473-474.
J. Med Chem., (1992), 35, (12), pp. 2214-2220, compounds 2-6 from tables 1 and 2.
J. Chem. Soc. Perkin Trans. I 1984, pp. 1929-1932.
Chemical Abstracts, 70:37598; compound with registry Nos. 21421-40-9 and compound with registry No. 21421-41-0, 1966.
Chemical Abstracts, 134:360953; compound with registry Nos. 340719-96-2, 2000.
“Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery” H.H. Fiebig et al. European Journal of Cancer 2004, 40, 802-820.
Search report from Belarus Patent Office, 2001.

Affiliated with

Also associated with

Rating

Indole derivatives and their use as medicament does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole derivatives and their use as medicament, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives and their use as medicament will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2632529